Advertisement
Advertisement
Trending on Urology Times
1
Joshua Halpern, MD, MS, on the clinical role of mail-in semen analysis
2
Why accurate CIS diagnosis matters in bladder cancer care
3
Darlifarnib plus cabozantinib shows encouraging antitumor activity in ccRCC
4
Matthew Galsky, MD, on how EV/pembrolizumab is redefining the MIBC treatment paradigm
5